Pharmacogenetics
Hereditary Cancer
Trisome 21, 18, 13
Carrier Screening
Pharmacovigilance is the active collection, detection, monitoring and prevention of Adverse Drug Reactions (ADR).
The mapping of the human genome has provided medical professionals with the ability to refine a patient’s cancer risk through the analysis of inherited mutations.
Luminus is validated for pregnant women of any age or risk categories and trusted by clinicians worldwide.
Genetic Carrier Screening tests provide physicians with information about the risks of inherited diseases of their patients’ future children.
